Outcomes for the Commercial Use of Self-Expanding Prostheses in Transcatheter Aortic Valve Replacement: A Report From the STS/ACC TVT Registry
Conclusions
Commercial adoption of the Evolut R platform is associated with significant improvements in acute outcomes for patients undergoing TAVR for aortic stenosis.
Source: Journal of the American College of Cardiology: Cardiovascular Interventions - Category: Cardiology Authors: Sorajja, P., Kodali, S., Reardon, M. J., Szeto, W. Y., Chetcuti, S. J., Hermiller, J., Chenoweth, S., Adams, D. H., Popma, J. J. Tags: Structural Source Type: research
More News: Aortic Stenosis | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Heart | Heart Valve Surgery